Clinical Trial Update: Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the cardiovascular effects of Angiotensin-(1-7) in obesity and hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Obesity, Hypertension | EARLY_Phase 1 | Status: RECRUITING